News
- May 12, 2011 | U.S. Dept. of Health and Human Services
HHS Announces Action Plan to Prevent and Treat Viral Hepatitis
The U.S. Department of Health and Human Services today launched its action plan to prevent and treat viral hepatitis, a silent epidemic affecting 3.5 – 5.3 million Americans.
Read More > - May 05, 2011 | CDC's Morbidity and Mortality Weekly Report
Hepatitis C Virus Infection Among Adolescents and Young Adults - Massachusetts, 2002-2009
Nationwide, rates of acute, symptomatic HCV infection declined during 1992-2005 and then began to level. Declines also were observed in rates of newly reported HCV infection in Massachusetts. Although these declines were evident among reported cases overall in Massachusetts during 2002-2006, an increase was observed among cases in the 15-24 year age group. In response to this increase, the Massachusetts Department of Public Health launched a surveillance initiative to collect more detailed information on cases reported during 2007-2009 among this younger age group and to examine the data for trends through 2009. The findings indicate the need for enhanced surveillance of HCV infection and intensified hepatitis C prevention efforts targeting adolescents and young adults.
Read Article > - May 05, 2011 | CDC's Morbidity and Mortality Weekly Report
Hepatitis Awareness Month - May 2011
This month marks the 16th anniversary of Hepatitis Awareness Month in the United States. Viral hepatitis, particularly infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), is a major cause of morbidity and mortality. This issue of MMWR includes a report that focuses on a recent trend in HCV infection.
Read Article > - April 16, 2011 | Medical Journal of Australia
More Support Needed To Cut HCV Toll
Better support for patients with drug and alcohol dependency could help reduce complications from hepatitis C virus (HCV) infection a new study published in the Medical Journal of Australia has found.
Read Article > - April 12, 2011 | HIV and Hepatitis.com
BMS-790052/BMS-650032 Combo Cures Hepatitis C without Interferon
A report on a study presented at the European Association for the Study of the Liver conference.
Read Article > - April 12, 2011 | Biology News Net
New compounds show promise against hepatitis C infection
Dr. Samuel Wheeler French Jr., MD, PhD, Assistant Professor of Pathology and Laboratory Medicine at UCLA and researcher at UCLA's Jonsson Comprehensive Cancer Center, is evaluating the effects of several flavonoids on hepatitis C viral infection.
Read Release > - April 06, 2011 | Roche
Roche Joins in Spanish Research Cooperation for Personalized Treatment of Hepatitis B and C
Roche Diagnostics is cooperating with the Spanish Vall d’Hebron Institute of Research, the Networking Biomedical Research Centre in Liver and Digestive Diseases, and the software producer Advanced Biological Laboratories Therapy Edge Spain in a study designed to resolve the current limitations that prevent the individualization of anti-HBV and anti-HCV (hepatitis B and C) treatments.
Read Release > - April 01, 2011 | HBV Journal Review
HBV Infection Rate in the United States Drops from 5.1% to 4.6%
A national study to determine the incidence of hepatitis B virus (HBV) infection nationwide estimates that 0.27% of the U.S. population has chronic hepatitis B, according to a report in the March 2010 issue of the Annals of Internal Medicine.
Read Article > - March 01, 2011 | Reuters Health
U.S. adults still have low rates of HBV immunity
Kids in the U.S. these days are largely immune to the hepatitis B virus (HBV), but high-risk adults still have low vaccination rates, according to a new study.
Read Article > - March 01, 2011 | HBV Journal Review
Early Hepatitis B Screening and Treatment Saves Lives and Health Care Dollars
Early diagnosis and treatment of hepatitis B cuts health care costs and decreases death rates among patients infected with the hepatitis B virus (HBV), according to a study by New York School of Medicine and University of Pennsylvania School of Medicine researchers.
Read Article >